Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Russneft reported for 6 months of 2024 by IFRS

8/23/24 RNFT

Driving school Svetofor reported for 6 months of 2024 by RAS

8/23/24 SVET

Nizhnekamskneftekhim reported for 6 months of 2024 by RAS

8/23/24 NKNC

Kazanorgsintez reported for 6 months of 2024 by RAS

8/23/24 KZOS

Nornickel reported for 6 months of 2024 by IFRS

8/23/24 GMKN

Rosbank reported for 6 months of 2024 by IFRS

8/23/24 ROSB

Etalon's sales hit a monthly record

8/23/24 ETLN

Board of Directors of Novorossiysk Bakery Products Plant recommended dividends

8/23/24 NKHP

O'Key reported for 6 months of 2024 by IFRS

8/23/24 OKEY

Board of Directors of Bank St. Petersburg recommended that dividends be paid for 6 мес. 2024

8/23/24 BSPB